IL1B and glioblastoma: Kaplan-Meier survival curves demonstrated that pharmacologically antagonizing IL-1β or IL-1R1 prolonged the survival of GBM-bearing mice (median survival = 47 and 46 days, respectively) relative to vehicle controls (median survival = 40 days) (Figure 9B, P < 0.05).